Department of Neurology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.
Eur J Neurol. 2013 Jul;20(7):1017-24, e87. doi: 10.1111/ene.12094. Epub 2013 Feb 9.
Endovascular therapy is used increasingly for treatment of acute symptomatic internal carotid artery (ICA) occlusion, although randomized trials are lacking. Predictors of outcome are therefore of special interest.
From 1992 to 2010 we treated 201 patients with acute ICA occlusion with intra-arterial pharmacological thrombolysis (32), endovascular mechanical therapy (78) or a combination of both (91). All data were assessed prospectively.
There were 76/38% patients with tandem occlusions [ICA plus middle (MCA) or anterior cerebral arteries (ACA)], 18/9% without concomitant occlusions of major intracranial arteries (ICA plus branch occlusion) and 107/53% with functional ICA-T occlusions (ICA plus MCA and ACA). Median baseline National Institute of Health Stroke Scale (NIHSS) score was 17. Good recanalization (Thrombolysis in Myocardial Infarction 2-3) was achieved in (157/201) 78% patients and good reperfusion (Thrombolysis in Cerebral Infarction 2-3) in (151/182) 83%. Better recanalization rates were obtained with mechanical approaches, with/without thrombolytics (78/91 = 86% and 64/78 = 82%) compared with pharmacological thrombolysis only (15/32 = 47%; P < 0.001). Twelve patients (6%) suffered symptomatic intracranial haemorrhages. The 3-month outcome was favourable [modified Rankin score (mRS) 0-2] in 54/28% patients and moderate (mRS 0-3) in 90/46%; 60/31% patients died. Only 17/16% patients with functional ICA-T occlusions had favourable outcomes compared with 32/44% with tandem occlusions and 5/31% with ICA plus cerebral branch occlusions (P = 0.001). In multivariate analysis age [odds ratio (OR) = 0.96, 95% confidence interval (CI) = 0.93-0.98], NIHSS on admission (OR = 0.9, 95% CI = 0.83-0.98) and functional ICA-T occlusion (OR = 0.35, 95% CI = 0.16-0.77) were non-modifiable predictors, and vessel recanalization was the only modifiable predictor of outcome (OR = 9.30, 95% CI = 2.03-42.63).
The outcome of acute symptomatic ICA occlusion is poor. However, recanalization is associated with better outcome, and recanalization rates with mechanical techniques were superior to merely pharmacological recanalization attempts.
血管内治疗越来越多地用于治疗急性症状性颈内动脉(ICA)闭塞,但缺乏随机试验。因此,预测结果特别重要。
1992 年至 2010 年,我们对 201 例急性 ICA 闭塞患者进行了治疗,包括动脉内药物溶栓(32 例)、血管内机械治疗(78 例)或两者联合治疗(91 例)。所有数据均前瞻性评估。
76/38%的患者存在串联闭塞[ICA 加中动脉(MCA)或前脑动脉(ACA)],18/9%的患者无颅内主要动脉同时闭塞(ICA 加分支闭塞),107/53%的患者存在功能性 ICA-T 闭塞(ICA 加 MCA 和 ACA)。基线 NIHSS 评分中位数为 17。157/201(78%)患者实现了良好的再通(血栓切除术治疗心肌梗死 2-3 级),151/182(83%)患者实现了良好的再灌注(血栓切除术治疗脑梗死 2-3 级)。机械方法(联合/不联合溶栓)与单独药物溶栓相比(78/91=86%和 64/78=82%),再通率更高(78/91=86%和 64/78=82%)。12 名患者(6%)发生症状性颅内出血。3 个月时预后良好(改良 Rankin 评分(mRS)0-2)为 54/28%的患者,中度(mRS 0-3)为 90/46%;60/31%的患者死亡。只有 17/16%的功能性 ICA-T 闭塞患者预后良好,与 32/44%的串联闭塞患者和 5/31%的 ICA 加脑分支闭塞患者相比(P=0.001)。多变量分析显示,年龄[优势比(OR)=0.96,95%置信区间(CI)=0.93-0.98]、入院时 NIHSS(OR=0.9,95%CI=0.83-0.98)和功能性 ICA-T 闭塞(OR=0.35,95%CI=0.16-0.77)是不可改变的预测因素,血管再通是唯一可改变的预后预测因素(OR=9.30,95%CI=2.03-42.63)。
急性症状性 ICA 闭塞的预后较差。然而,再通与更好的预后相关,机械技术的再通率优于单纯药物再通尝试。